Richard Watson
Richard Watson
approved becomes concern fda generic prices valid whether
I think what is a valid concern is an overburdened FDA, and whether the FDA becomes more of a bottleneck to getting new generic drugs approved and getting the prices of drugs down,
controlled easier focus group industry patients potential products smaller specialty specific
Specialty pharmaceutical companies, those smaller firms in the industry that focus on specific therapeutic areas, have a well- controlled group of potential patients that makes their products easier to monitor,